ST新梅(600732.SH):廣東愛旭擬向浙江愛旭增資3億元
格隆匯11月25日丨ST新梅(600732.SH)公佈,為優化浙江愛旭太陽能科技有限公司(以下簡稱“浙江愛旭”)的資產結構,增強其資金實力,公司全資子公司廣東愛旭科技有限公司(以下簡稱“廣東愛旭”)擬使用其自有資金對其全資子公司浙江愛旭進行增資,增資金額為人民幣3億元,增資款將分期支付。增資完成後,浙江愛旭的註冊資本由人民幣6億元變更為9億元,股權結構不變,仍然由廣東愛旭持有浙江愛旭100%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.